Table 4.
Mechanism | Example | “Parent allele” | Mutation | Antigens lost | Antigens expressed |
---|---|---|---|---|---|
Gene conversion | E category II 89 | cE | Ce-D(2–3)-ce | ||
90 | Ce | RHCE-D(4)-CE | Rh46 | Rh32 | |
Ce | RHCE-D(3 partial-4)-CE | ||||
R 0 Har 31 | ce * | RHCE-D(5)-CE | Rh33, Rh50 | ||
CeVA 91 | Ce | RHCE-D(5)-CE | Rh33, Rh50 | ||
Missense mutation (exofacial) | C X 92 | Ce | A36T | MAR | CX |
C W 92 | Ce | Q41R | MAR | CW | |
RH:-26 93 | ce | G96S | Rh26 | ||
CeMA | Ce | R114W | (Har*) | ||
E cat V = EHK 28 | cE | R154T | E epitopes | ||
ceRT 32 | ce | R154T | D epitope 6 | ||
E cat I 89 | E | M167K | E epitopes | ||
E cat III 89 | E | Q233E, M238V | E epitopes | ||
Missense mutation (non-exofacial) | E cat IV 89 | E | R201T | E epitopes ? | |
VS 70 | ce(W16C) † | L245V | VS | ||
In-frame-deletion | e U 95 | Del 229 | Very weak e |
RBC samples harboring this allele react with human serum Har. It is unknown whether the target antigen of this serum is identical to a known low-frequency antigen of the Rh blood group